Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Chemosensitivity test for human osteosarcoma cells]

C Liu1, G Dai, X Zhang

  • 1Institute of Orthopaedics, Second Teaching Hospital, Lanzhou Medical College.

Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|November 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Uptake of particulate lead via the gills of fish (Carassius auratus).

Archives of environmental contamination and toxicology·1999
Same author

Application of acupuncture and moxibustion for keeping shape.

Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan·1999
Same author

Two-effective-source method for the calculation of in-air output at various source-to-detector distances in wedged fields.

Medical physics·1999
Same author

Follow up of women with simple ovarian cysts detected by transvaginal sonography in the Tokyo metropolitan area.

British journal of obstetrics and gynaecology·1999
Same author

(R)-3,3,3-Trifluoro-2-hydroxy-2-methylpropionamides are orally active inhibitors of pyruvate dehydrogenase kinase.

Journal of medicinal chemistry·1999
Same author

Expression analysis of multidrug resistance associated genes in neuroblastomas.

Oncology reports·1999
Same journal

[shRNA-mediated downregulation of TERT inhibits melanoma in vitro and in vivo].

Zhonghua zhong liu za zhi [Chinese journal of oncology]·2026
Same journal

[Exploration on the application of perineal lateral arc-shaped incision in the resection of complex tumors on the lateral side of the pelvic floor].

Zhonghua zhong liu za zhi [Chinese journal of oncology]·2026
Same journal

[Risk stratification assessment of brain metastasis in newly diagnosed non-stage IV breast cancer patients with HER-2-low expression following systemic therapy].

Zhonghua zhong liu za zhi [Chinese journal of oncology]·2026
Same journal

[Clinicopathological analysis of SMARCA4-deficient tumors of digestive system origin].

Zhonghua zhong liu za zhi [Chinese journal of oncology]·2026
Same journal

[cfDNA sequencing reveals response heterogeneity to first-line camrelizumab plus chemotherapy in esophageal squamous cell carcinoma].

Zhonghua zhong liu za zhi [Chinese journal of oncology]·2026
Same journal

[Efficacy and safety of combination immunotherapy for locally advanced esophageal carcinoma].

Zhonghua zhong liu za zhi [Chinese journal of oncology]·2026
See all related articles

Osteosaroma (OS) cells showed sensitivity to specific chemotherapy drugs like mitomycin C (MMC) and plerixafor (PMB) at calculated in vivo concentrations. Higher concentrations revealed sensitivity to additional agents, with 72-hour exposure yielding the highest positive rates.

Area of Science:

  • Oncology
  • Pharmacology
  • Cell Biology

Context:

  • Osteosarcoma (OS) is a primary bone cancer with limited treatment options.
  • In vitro drug sensitivity testing is crucial for personalized cancer therapy.
  • Evaluating novel drug combinations and concentrations can improve treatment efficacy.

Purpose:

  • To determine the in vitro sensitivity of fresh osteosarcoma tissues to various chemotherapy drugs.
  • To investigate the time-effect relationship of drug sensitivity in osteosarcoma cells.
  • To identify effective drug concentrations for potential clinical application.

Summary:

  • Human osteosarcoma cells from 23 fresh tissues were tested for sensitivity to HDMTX, VCR, CBP, MMC, VP16, and PMB using MTT assays.
  • Osteosarcoma exhibited sensitivity to mitomycin C (MMC) and plerixafor (PMB) at calculated in vivo concentrations.

Related Experiment Videos

  • At five times the in vivo concentrations, sensitivity was observed for HDMTX, CBP, MMC, and PMB, with peak sensitivity at 72 hours (55.1% positive rate).

    • Impact:

    • This study provides valuable data for optimizing chemotherapy regimens in osteosarcoma patients.
    • Identifies specific drugs and concentrations that demonstrate significant in vitro efficacy.
    • Highlights the importance of time-dependent drug response in osteosarcoma treatment strategies.